€174.60
0.80% yesterday
Xetra, Nov 07, 05:35 pm CET
ISIN
DE0007165607
Symbol
SRT
Index

Sartorius Stock price

€174.60
-6.80 3.75% 1M
-10.60 5.72% 6M
+2.20 1.28% YTD
-15.60 8.20% 1Y
-123.90 41.51% 3Y
-161.40 48.04% 5Y
+118.48 211.09% 10Y
+168.88 2,949.78% 20Y
Xetra, Closing price Fri, Nov 07 2025
-1.40 0.80%
ISIN
DE0007165607
Symbol
SRT
Index

New AI Insights on Sartorius Insights AI Insights on Sartorius

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
€14.0b
Enterprise Value
€17.8b
Net debt
€3.8b
Cash
€430.6m
Shares outstanding
69.0m
Valuation (TTM | estimate)
P/E
90.7 | 35.0
P/S
4.0 | 3.9
EV/Sales
5.1 | 5.0
EV/FCF
37.3
P/B
5.2
Dividends
DPS
€0.73
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
0.0% | 15.8%
Payout 1Y | 3Y
59.8% | 20.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€3.5b | €3.6b
EBITDA
€923.0m | €1.0b
EBIT
€494.4m | €620.7m
Net Income
€133.7m | €347.1m
Free Cash Flow
€478.6m
Growth (TTM | estimate)
Revenue
5.8% | 6.2%
EBITDA
15.0% | 20.6%
EBIT
18.6% | 38.3%
Net Income
60.7% | 313.2%
Free Cash Flow
-0.1%
Margin (TTM | estimate)
Gross
46.5%
EBITDA
26.2% | 29.1%
EBIT
14.1%
Net
3.8% | 9.7%
Free Cash Flow
13.6%
Financial Health
Equity Ratio
27.4%
Return on Equity
3.0%
ROCE
6.3%
ROIC
4.3%
Debt/Equity
1.6
More
EPS
€1.9
FCF per Share
€6.9
Short interest
-
Employees
14k
Rev per Employee
€250.0k
Show more

Is Sartorius a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Sartorius Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Sartorius forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Sartorius forecast:

Buy
75%
Hold
25%

Financial data from Sartorius

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
3,517 3,517
6% 6%
100%
- Direct Costs 1,882 1,882
1% 1%
54%
1,635 1,635
12% 12%
46%
- Selling and Administrative Expenses 894 894
1% 1%
25%
- Research and Development Expense 191 191
3% 3%
5%
923 923
15% 15%
26%
- Depreciation and Amortization 429 429
11% 11%
12%
EBIT (Operating Income) EBIT 494 494
19% 19%
14%
Net Profit 134 134
61% 61%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Head office Germany
CEO Joachim Kreuzburg
Employees 13,573
Founded 1870
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today